Completed
A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
I8H-MC-BDCM - ClinicalTrials.gov - NCT03736785
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.
How long will I be in the trial?
The study will last about 39 weeks and may include up to 23 visits.
Completed
A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
I8H-MC-BDCM - ClinicalTrials.gov - NCT03736785
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.
How long will I be in the trial?
The study will last about 39 weeks and may include up to 23 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must NOT
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
interventions example
Could I receive a Placebo?
no
Enrollment Goal
375
Trial Dates
November 2018 - February 2020
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must NOT
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
interventions example
Could I receive a Placebo?
no
Enrollment Goal
375
Trial Dates
November 2018 - February 2020
Trial Phase
2
Not the right fit? Sign up to receive updates on new Adult Type 2 Diabetes trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Adult Type 2 Diabetes Resources
